NO20031532L - Pravastatinnatrium, hovedsakelig fri for pravastatinlacton og epi-pravastatin, og preparater inneholdende dette - Google Patents

Pravastatinnatrium, hovedsakelig fri for pravastatinlacton og epi-pravastatin, og preparater inneholdende dette

Info

Publication number
NO20031532L
NO20031532L NO20031532A NO20031532A NO20031532L NO 20031532 L NO20031532 L NO 20031532L NO 20031532 A NO20031532 A NO 20031532A NO 20031532 A NO20031532 A NO 20031532A NO 20031532 L NO20031532 L NO 20031532L
Authority
NO
Norway
Prior art keywords
pravastatin
epi
lactone
preparations containing
sodium
Prior art date
Application number
NO20031532A
Other languages
English (en)
Other versions
NO20031532D0 (no
Inventor
Vilmos Keri
Lajos Deak
Ilona Forgacs
Csaba Szabo
Arvai Edit Nagyne
Original Assignee
Biogal Gyogyszergyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22897222&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20031532(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biogal Gyogyszergyar filed Critical Biogal Gyogyszergyar
Publication of NO20031532D0 publication Critical patent/NO20031532D0/no
Publication of NO20031532L publication Critical patent/NO20031532L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/04—Sodium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/38—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/52—Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20031532A 2000-10-05 2003-04-04 Pravastatinnatrium, hovedsakelig fri for pravastatinlacton og epi-pravastatin, og preparater inneholdende dette NO20031532L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23827800P 2000-10-05 2000-10-05
PCT/US2001/031230 WO2002030415A1 (en) 2000-10-05 2001-10-05 Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same

Publications (2)

Publication Number Publication Date
NO20031532D0 NO20031532D0 (no) 2003-04-04
NO20031532L true NO20031532L (no) 2003-04-04

Family

ID=22897222

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031532A NO20031532L (no) 2000-10-05 2003-04-04 Pravastatinnatrium, hovedsakelig fri for pravastatinlacton og epi-pravastatin, og preparater inneholdende dette

Country Status (18)

Country Link
EP (1) EP1330245A4 (no)
JP (6) JP3737801B2 (no)
KR (1) KR20030059173A (no)
CN (1) CN1468098A (no)
AU (1) AU2002211462A1 (no)
CA (1) CA2422744A1 (no)
CZ (1) CZ20031166A3 (no)
HR (1) HRP20030347A2 (no)
HU (1) HUP0400913A2 (no)
IL (1) IL155194A0 (no)
IS (1) IS6766A (no)
MX (1) MXPA03002963A (no)
NO (1) NO20031532L (no)
NZ (1) NZ525631A (no)
PL (1) PL361230A1 (no)
SK (1) SK5232003A3 (no)
WO (1) WO2002030415A1 (no)
ZA (1) ZA200302313B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2393057C (en) * 1999-11-30 2008-01-29 Biogal Gyogyszergyar Rt. Process for recovering pravastatin from a fermentation broth
EP1481674B1 (en) * 1999-11-30 2008-01-02 TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság Process for recovering statin compounds from a fermentation broth
EP1798214A3 (en) * 1999-11-30 2007-08-01 Teva Gyogyszergyár Zártköruen Muködo Részvenytarsaság Process for recovering statin compounds from a fermentation broth
SK8312002A3 (en) 1999-12-14 2003-05-02 Biogal Gyogyszergyar Novel forms of pravastatin sodium
WO2002030415A1 (en) * 2000-10-05 2002-04-18 Biogal Gyogyszergyar Rt Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same
JP3236282B1 (ja) * 2000-10-16 2001-12-10 三共株式会社 プラバスタチンを精製する方法
GB0218781D0 (en) 2002-08-13 2002-09-18 Astrazeneca Ab Chemical process
EP1452519A1 (en) * 2003-02-25 2004-09-01 Balkanpharma-Razgrad AD Method for the isolation and purification of pravastatin sodium
GB0312896D0 (en) 2003-06-05 2003-07-09 Astrazeneca Ab Chemical process
UY28501A1 (es) 2003-09-10 2005-04-29 Astrazeneca Uk Ltd Compuestos químicos
GB0324791D0 (en) 2003-10-24 2003-11-26 Astrazeneca Ab Chemical process
DE04811862T1 (de) 2003-11-24 2006-03-02 Teva Gyogyszergyar Reszvenytarsasag Verfahren zur Reinigung von Pravastatin
KR20070038553A (ko) 2004-08-06 2007-04-10 트렌스폼 파마수티컬스 인코퍼레이티드 신규한 스타틴 약제학적 조성물 및 관련된 치료방법
ES2254028B1 (es) * 2004-11-29 2007-03-01 Ercros Industrial, S.A. Procedimiento para la obtencion de pravastatina sodica purificada.
EP1851223A1 (en) * 2005-02-25 2007-11-07 Teva Pharmaceutical Industries Ltd Process of purifying tadalafil
JP4813841B2 (ja) * 2005-07-25 2011-11-09 キユーピー株式会社 プラバスタチンナトリウムの製造方法
HU229260B1 (en) * 2010-11-29 2013-10-28 Egis Gyogyszergyar Nyrt Process for preparation of rosuvastatin salts
CN114031496A (zh) * 2021-11-30 2022-02-11 广东蓝宝制药有限公司 一种高纯度普伐他汀1,1,3,3-四甲基丁胺的制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3378441A (en) * 1963-10-17 1968-04-16 S B Penick & Company Tetraene antibiotic purification
JPS5221594B2 (no) * 1973-09-29 1977-06-11
IT1059403B (it) * 1975-02-07 1982-05-31 Glaxo Lab Ltd Procedimento per produrre acido clavulanico e suoi derivati nonche composizioni che lo contengono
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
DK149080C (da) * 1980-06-06 1986-07-28 Sankyo Co Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
JPS572240A (en) * 1980-06-06 1982-01-07 Sankyo Co Ltd Ml-236b derivative
JPS5889191A (ja) * 1981-11-20 1983-05-27 Sankyo Co Ltd ３−ヒドロキシ−ｍｌ−２３６ｂ誘導体の製造法
JPS5890509A (ja) * 1981-11-25 1983-05-30 Sankyo Co Ltd 高コレステロ−ル血症治療用組成物
JPH01190661A (ja) * 1988-01-22 1989-07-31 Konishi Kagaku Kogyo Kk ４，４′−ジヒドロキシジフエニルスルホンの精製法
JP2739328B2 (ja) * 1988-09-14 1998-04-15 日本ケミファ株式会社 ベンズイミダゾール化合物の精製方法
US5202029A (en) * 1991-03-13 1993-04-13 Caron Kabushiki Kaisha Process for purification of hmg-coa reductase inhibitors
NZ250609A (en) * 1992-12-28 1995-07-26 Sankyo Co Hexahydronaphthalene esters and ring closed lactones; preparation and medicaments
JPH06256278A (ja) * 1993-03-03 1994-09-13 Nissan Chem Ind Ltd 光学活性α−カルバモイルアルカン酸誘導体およびその製法
CA2126365C (en) * 1993-07-06 1999-08-24 Steven W. Felman Recovery of citric acid from impure process streams by addition of strong acids and salts thereof
ATE159051T1 (de) * 1994-03-31 1997-10-15 Cultor Oy Verfahren zur rückgewinnung von natamycin
DK0784605T3 (da) * 1995-08-03 2000-07-31 Dsm Nv Selektiv fremgangsmåde til deacyleringen af acylforbindelser
JPH09124655A (ja) * 1995-11-01 1997-05-13 Sankyo Co Ltd 新規スクアレンシンターゼ阻害活性化合物
EP0877089A1 (en) * 1997-05-07 1998-11-11 Gist-Brocades B.V. HMG-CoA reductase inhibitor preparation process
SI20070A (sl) * 1998-09-18 2000-04-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Nove soli inhibitorjev HMG-CoA reduktaze
SI20072A (sl) * 1998-09-18 2000-04-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze
JP2000229855A (ja) * 1998-12-07 2000-08-22 Satoshi Takebe プラバスタチンナトリウム錠
TR200600009T2 (tr) * 1999-02-03 2006-08-21 Institute For Drug Research Ltd. Pravastatinin hazırlanması için mikrobiyal işlem.@
HUP9902352A1 (hu) * 1999-07-12 2000-09-28 Gyógyszerkutató Intézet Kft. Eljárás pravasztatin mikrobiológiai előállítására
CA2393057C (en) * 1999-11-30 2008-01-29 Biogal Gyogyszergyar Rt. Process for recovering pravastatin from a fermentation broth
WO2002030415A1 (en) * 2000-10-05 2002-04-18 Biogal Gyogyszergyar Rt Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same

Also Published As

Publication number Publication date
PL361230A1 (en) 2004-10-04
CZ20031166A3 (cs) 2004-04-14
NO20031532D0 (no) 2003-04-04
CA2422744A1 (en) 2002-04-18
MXPA03002963A (es) 2005-01-25
CN1468098A (zh) 2004-01-14
HRP20030347A2 (en) 2005-04-30
JP2006036781A (ja) 2006-02-09
JP2004510817A (ja) 2004-04-08
IS6766A (is) 2003-04-01
EP1330245A1 (en) 2003-07-30
IL155194A0 (en) 2003-11-23
JP2009268479A (ja) 2009-11-19
SK5232003A3 (en) 2004-06-08
HUP0400913A2 (en) 2006-11-28
KR20030059173A (ko) 2003-07-07
NZ525631A (en) 2005-05-27
AU2002211462A1 (en) 2002-04-22
WO2002030415A1 (en) 2002-04-18
JP2013128486A (ja) 2013-07-04
JP3737801B2 (ja) 2006-01-25
EP1330245A4 (en) 2004-10-20
JP2005013238A (ja) 2005-01-20
JP2015212300A (ja) 2015-11-26
ZA200302313B (en) 2004-03-25
WO2002030415A9 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
NO20031532L (no) Pravastatinnatrium, hovedsakelig fri for pravastatinlacton og epi-pravastatin, og preparater inneholdende dette
NO20044192L (no) 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
NO20021401D0 (no) Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser
NO20071303L (no) Farmasoytiske preparater
ATE485823T1 (de) Kombinationspräparate enthaltend (e)-7-ä4-(4- fluorophenyl)-6-isopropyl-2-
DK1337529T3 (da) Heterocyclylalkylpiperidinderivater, deres fremstilling og præparater indeholdende dem
DK1329456T3 (da) Glucopyranosyloxybenzylbenzenderivater og medicinske sammensætninger indeholdende samme
NO20033556D0 (no) Farmasöytiske preparater
ID30590A (id) Celana sekali pakai jenis-celana pendek
HUP0302297A3 (en) Substituted thioacetamides and pharmaceutical compositions containing them
NO20004907L (no) Vandig emulsjon og fremstilling derav
NO20025357L (no) Antranylamider og deres anvendelse som legemidler
ID30187A (id) Dongkrak jenis pantagraf
DK1370550T3 (da) Quinolylpropylpiperidinderivater, deres fremstilling og præparater indeholdende dem
NO20026013L (no) Medisinske preparater inneholdende propenonderivater
NO20033506D0 (no) Parasittdrepende preparater og fremgangsmåter for anvendelse
IS6698A (is) Háhreinsaðar símvastatínblöndur
ITMI20011637A0 (it) Composizione farmaceutica contenente citalopram
EE05192B1 (et) Trptamiini derivaadid ja analoogsed hendid ning neid sisaldavad farmatseutilised preparaadid
EE200300468A (et) Pravastatiini stabiilne farmatseutiline kompositsioon
NO20024354D0 (no) N-deacetyltiocolchicin-derivater og farmasöytiske sammensetninger inneholdende dem
ATE317386T1 (de) Dihydroindol- und tetrahydrochinolinderivate
DK1406895T3 (da) Lactonformuleringer og fremgangsmåde til anvendelse deraf
NO20024823L (no) Medisinske preparater inneholdende camptothecin-derivat og pH regulerende middel
NO20033743D0 (no) Fremgangsmåte og fremstilling citalopram

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application